NCT01023529

Symptoms and Quality of Life (QoL) After Palliative Pelvic Radiation of Prostate and Rectal Cancers

A Prospective Multicenter Study of Symptoms and QOL in Patients With Prostate and Rectal Cancers Receiving Palliative Pelvic Radiation

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 98 (actual)
• Sponsor: Sorlandet Hospital HF · Other Government
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to assess the effect of palliative pelvic radiation on symptoms and quality of life among patients with incurable prostate and rectal cancer.

Detailed description

With the aging population, the prevalence of cancer is on the rise, leading to an increased demand for effective palliative treatment. There is little scientific information describing the effects of palliative radiotherapy among patients treated for soft-tissue tumors of the pelvis. This is a treatment that is used relatively frequently, but delivered heterogeneously since the optimum fractionation schedule has yet to be established. This study aims to define the effects of one such fractionation schedule (3Gy x 10-13) and thus, establish a foundation for future fractionation studies.

Conditions

• Prostatic Neoplasms
• Rectal Neoplasms

Interventions

Type	Name	Description
RADIATION	Palliative pelvic soft-tissue radiation (external beam)	3 Gy x 10-13 (range 30 - 39 Gy total)

Timeline

• Start date: 2009-11-01
• Primary completion: 2015-07-01
• Completion: 2015-07-01
• First posted: 2009-12-02
• Last updated: 2015-11-18

Locations

8 sites across 1 country: Norway